Evidence-Based Medicine Guidelines
Dapsone as an oral corticosteroid sparing agent for asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dapsone as an Oral Corticosteroid Sparing Agent for Asthma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453193/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma.
Dapsone as an oral corticosteroid sparing agent for asthma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453193/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma. Accessed March 23, 2025.
Dapsone as an oral corticosteroid sparing agent for asthma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453193/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma
Dapsone as an Oral Corticosteroid Sparing Agent for Asthma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453193/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dapsone as an oral corticosteroid sparing agent for asthma
ID - 453193
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453193/all/Dapsone_as_an_oral_corticosteroid_sparing_agent_for_asthma
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
